Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Antonio Gasbarrini and Gianmaria Cammarota.
Antonio Gasbarrini
Connection Strength
6.452
Gianmaria Cammarota
  1. Gut microbiome beats two to zero host genome. Hepatobiliary Surg Nutr. 2019 Aug; 8(4):378-380.
    View in: PubMed
    Score: 0.835
  2. Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank. Dig Liver Dis. 2021 11; 53(11):1428-1432.
    View in: PubMed
    Score: 0.237
  3. SARS-CoV-2 vaccines and donor recruitment for FMT. Lancet Gastroenterol Hepatol. 2021 04; 6(4):264-266.
    View in: PubMed
    Score: 0.232
  4. Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study. Dig Liver Dis. 2020 12; 52(12):1390-1395.
    View in: PubMed
    Score: 0.226
  5. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut. 2020 09; 69(9):1555-1563.
    View in: PubMed
    Score: 0.223
  6. The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center. Endosc Int Open. 2020 Jul; 8(7):E980-E984.
    View in: PubMed
    Score: 0.222
  7. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020 05; 5(5):430-432.
    View in: PubMed
    Score: 0.218
  8. A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial. Nutrients. 2019 Mar 27; 11(4).
    View in: PubMed
    Score: 0.204
  9. The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer. Int J Mol Sci. 2019 Jan 24; 20(3).
    View in: PubMed
    Score: 0.201
  10. Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center. Int J Infect Dis. 2019 Mar; 80:105-110.
    View in: PubMed
    Score: 0.201
  11. Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? Int J Mol Sci. 2019 Jan 06; 20(1).
    View in: PubMed
    Score: 0.201
  12. Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018 Aug 12; 10(8).
    View in: PubMed
    Score: 0.195
  13. Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis. United European Gastroenterol J. 2018 Oct; 6(8):1232-1244.
    View in: PubMed
    Score: 0.193
  14. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Aliment Pharmacol Ther. 2018 07; 48(2):152-159.
    View in: PubMed
    Score: 0.193
  15. Helicobacter pylori in metabolic related diseases. Minerva Gastroenterol Dietol. 2018 Sep; 64(3):297-309.
    View in: PubMed
    Score: 0.190
  16. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update. Drugs Today (Barc). 2018 Feb; 54(2):123-136.
    View in: PubMed
    Score: 0.188
  17. Letter by Ianiro et al Regarding Article, "Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium". Circulation. 2018 01 09; 137(2):213-214.
    View in: PubMed
    Score: 0.187
  18. Fecal microbiota transplantation: past, present and future perspectives. Minerva Gastroenterol Dietol. 2017 Dec; 63(4):420-430.
    View in: PubMed
    Score: 0.186
  19. Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab. PLoS One. 2017; 12(10):e0186575.
    View in: PubMed
    Score: 0.185
  20. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders. Dig Dis. 2018; 36(1):56-65.
    View in: PubMed
    Score: 0.181
  21. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year cohort study: authors' reply. Clin Microbiol Infect. 2017 11; 23(11):891.
    View in: PubMed
    Score: 0.179
  22. Faecal microbiota transplantation in clinical practice. Gut. 2018 01; 67(1):196-197.
    View in: PubMed
    Score: 0.178
  23. The gut microbiota: its anatomy and physiology over a lifetime. Minerva Gastroenterol Dietol. 2017 Dec; 63(4):329-336.
    View in: PubMed
    Score: 0.178
  24. Ipilimumab Adjuvant Therapy in Melanoma. N Engl J Med. 2017 01 26; 376(4):398.
    View in: PubMed
    Score: 0.175
  25. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017 04; 66(4):569-580.
    View in: PubMed
    Score: 0.175
  26. Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide. Gastroenterol Res Pract. 2017; 2017:8646495.
    View in: PubMed
    Score: 0.175
  27. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Clin Microbiol Infect. 2017 May; 23(5):337.e1-337.e3.
    View in: PubMed
    Score: 0.175
  28. Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives. Mediators Inflamm. 2013; 2013:391473.
    View in: PubMed
    Score: 0.136
  29. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther. 2005 Dec; 22(11-12):1157-60.
    View in: PubMed
    Score: 0.081
  30. Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19. Aliment Pharmacol Ther. 2020 Sep; 52(5):902-903.
    View in: PubMed
    Score: 0.056
  31. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm Bowel Dis. 2020 08 20; 26(9):1306-1314.
    View in: PubMed
    Score: 0.056
  32. Wheat desensitization treatment in patients with gluten sensitivity. Postepy Dermatol Alergol. 2018 Jun; 35(3):320-322.
    View in: PubMed
    Score: 0.048
  33. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. Aliment Pharmacol Ther. 1998 Jun; 12(6):539-43.
    View in: PubMed
    Score: 0.048
  34. Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease. Dig Dis. 2018; 36(3):184-193.
    View in: PubMed
    Score: 0.047
  35. Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study. Scand J Gastroenterol. 2018 05; 53(5):567-572.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.